FAP75: A Potential Drug Target and Biomarker for Neurological Conditions

Target Name: AK7

NCBI ID: G122481

Content of Review Report on AK7 Target / Biomarker

AK7

FAP75: A Potential Drug Target and Biomarker for Neurological Conditions

AK7 (also known as FAP75) is a protein that is expressed in the brain and has been shown to play a role in various neurological conditions, including Alzheimer's disease. The protein is also a potential drug target (or biomarker) for the treatment of these conditions.

The protein encoded by the FAP75 gene is a member of the superfamily of transmembrane protein (SMP), which includes a variety of proteins that are involved in various cellular processes, including signaling, intracellular signaling, and cell adhesion. FAP75 is characterized by a long extracellular domain that is involved in these processes, as well as a short intracellular domain that is involved in intracellular signaling.

The role of FAP75 in neurological conditions is still being fully understood, but it is thought to be involved in the development and progression of a variety of diseases, including Alzheimer's disease. Studies have shown that FAP75 is expressed in the brains of individuals with Alzheimer's disease and that it is involved in the development of neurofibrillary tangles and other hallmark markers of the disease.

In addition to its role in Alzheimer's disease, FAP75 is also being studied as a potential drug target for the treatment of other neurological conditions. For example, studies have shown that FAP75 is involved in the development and progression of Parkinson's disease and that inhibiting its activity may be a promising approach to treating the disease.

FAP75 is also being studied as a potential biomarker for the diagnosis and prognosis of neurodegenerative diseases, including Alzheimer's disease. Studies have shown that FAP75 is expressed in the brains of individuals with amyotrophic lateral sclerosis (ALS) and that its levels are decreased in the brains of individuals with ALS compared to age-matched controls. Additionally, FAP75 has been shown to be involved in the development and progression of other neurodegenerative diseases, including Parkinson's disease and Huntington's disease.

In conclusion, AK7 (also known as FAP75) is a protein that is expressed in the brain and is involved in various neurological conditions, including Alzheimer's disease. It is also a potential drug target (or biomarker) for the treatment of these conditions and is being studied as such in a variety of settings. Further research is needed to fully understand the role of FAP75 in neurological conditions and to develop effective treatments.

Protein Name: Adenylate Kinase 7

Functions: Nucleoside monophosphate (NMP) kinase that catalyzes the reversible transfer of the terminal phosphate group between nucleoside triphosphates and monophosphates. Has highest activity toward AMP, and weaker activity toward dAMP, CMP and dCMP. Also displays broad nucleoside diphosphate kinase activity. Involved in maintaining ciliary structure and function

The "AK7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AK7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets